Gastro-oesophageal Reflux Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 75 years old
- People who have at least one of the following symptoms: upper abdominal pain, bloating, loss of appetite, acid reflux, or constipation
- People who are already taking a medicine called Danning Tablets as part of their regular treatment for indigestion
- People who are willing to sign a consent form agreeing to take part
Who may not be able to join:
- People who have a history of cancer or currently have cancer
- People who have serious conditions affecting the heart, brain, kidneys, or blood
- People who have had certain abdominal surgeries in the past (such as pancreatic surgery, partial stomach removal, or bowel obstruction surgery), or who have a mental illness or significant difficulty moving around (for example, those who are confined to bed long-term)
- People who have any unstable ongoing or sudden illness that a research doctor considers could affect how well the treatment results can be measured
- People who are pregnant or breastfeeding
- People who have taken part in another clinical trial within the last 3 months
- People who a research doctor determines are not suitable for the trial for other reasons (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jianting CAI, Doctor of Medicine, Second Affiliated Hospital, School of Medicine, Zhejiang University
Phone: +86 13818076897
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Dyspepsia symptoms responder rate post treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.